Bio-Techne
TECH
#1989
Rank
โ‚ฌ8.25 B
Marketcap
52,98ย โ‚ฌ
Share price
-2.93%
Change (1 day)
-23.77%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

Bio-Techne (TECH) - Total debt

Total debt on the balance sheet as of September 2025 : โ‚ฌ0.33 Billion

According to Bio-Techne's latest financial reports the company's total debt is โ‚ฌ0.33 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Bio-Techne - Total debt on balance sheet (from 1999 to 2025)

Total debt by year

Year Total debt Change
2024-06-30โ‚ฌ0.39 B-6.24%
2023-06-30โ‚ฌ0.41 B33.98%
2022-06-30โ‚ฌ0.31 B-12.29%
2021-06-30โ‚ฌ0.35 B-8.07%
2020-06-30โ‚ฌ0.38 B-13.2%
2019-06-30โ‚ฌ0.44 B53.45%
2018-06-30โ‚ฌ0.28 B-3.85%
2017-06-30โ‚ฌ0.30 B251.24%
2016-06-30โ‚ฌ85.77 M24%
2015-06-30โ‚ฌ69.17 M631.67%
2014-06-30โ‚ฌ9.45 M
2006-06-30โ‚ฌ10.6 M-13.43%
2005-06-30โ‚ฌ12.24 M-6.08%
2004-06-30โ‚ฌ13.03 M-12.72%
2003-06-30โ‚ฌ14.93 M-17.88%
2002-06-30โ‚ฌ18.19 M-18.38%
2001-06-30โ‚ฌ22.28 M7.82%
2000-06-30โ‚ฌ20.66 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Thermo Fisher Scientific
TMO
โ‚ฌ30.64 B 8,944.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Rad Laboratories
BIO
โ‚ฌ1.19 B 253.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
โ‚ฌ16.61 B 4,803.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Danaher
DHR
โ‚ฌ14.47 B 4,173.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Qiagen
QGEN
โ‚ฌ1.82 B 439.25%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
General Electric
GE
โ‚ฌ17.89 B 5,182.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
โ‚ฌ2.57 M-99.24%๐Ÿ‡บ๐Ÿ‡ธ USA